Suppr超能文献

沙特阿拉伯糖尿病患者中的 COVID-19：现状与新视角。

COVID-19 among people with diabetes mellitus in Saudi Arabia: Current situation and new perspectives.

机构信息

Department of Endocrinology and Diabetes, Diabetes Treatment Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

出版信息

Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102231. doi: 10.1016/j.dsx.2021.102231. Epub 2021 Jul 24.

DOI:10.1016/j.dsx.2021.102231
PMID:34330072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8302829/
Abstract

BACKGROUND AND AIM

This review aims to report the current status of COVID-19 among people with diabetes, newly diagnosed diabetes, diabetic ketoacidosis, and programmatic efforts including vaccinations.

METHODS

We conducted a literature search using PubMed, Google, and Scopus until July 15, 2021.

RESULTS

In Saudi Arabia, most studies have reported diabetes as one of the highly prevalent comorbidities among patients with COVID-19. Currently, there are limited studies from Saudi Arabia on the newly diagnosed diabetes and diabetic ketoacidosis caused by COVID-19. The Saudi ministry has taken several measures to control the impact of COVID-19 among people with diabetes, including comprehensive guidelines and prioritized vaccinations. During the COVID-19 pandemic, the use of telehealth services dramatically increased in diabetes clinics in Saudi Arabia.

CONCLUSIONS

Focused and evidence-based interventions are essential to control the impact of COVID-19 among people with diabetes.

摘要

背景与目的

本综述旨在报告 COVID-19 在糖尿病患者、新诊断糖尿病患者、糖尿病酮症酸中毒患者中的现状，以及包括疫苗接种在内的规划工作。

方法

我们使用 PubMed、Google 和 Scopus 进行了文献检索，检索截至 2021 年 7 月 15 日。

结果

在沙特阿拉伯，大多数研究报告称，糖尿病是 COVID-19 患者中高发的合并症之一。目前，沙特阿拉伯关于 COVID-19 导致的新诊断糖尿病和糖尿病酮症酸中毒的研究有限。沙特政府已采取多项措施来控制 COVID-19 对糖尿病患者的影响，包括制定综合指南和优先接种疫苗。在 COVID-19 大流行期间，沙特阿拉伯的糖尿病诊所大量使用远程医疗服务。

结论

需要有针对性和基于证据的干预措施来控制 COVID-19 对糖尿病患者的影响。

相似文献

1
COVID-19 among people with diabetes mellitus in Saudi Arabia: Current situation and new perspectives.
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102231. doi: 10.1016/j.dsx.2021.102231. Epub 2021 Jul 24.
2
COVID-19 in People with Diabetes: Perspectives from Saudi Arabia.
Curr Diabetes Rev. 2021;17(6):e111020187810. doi: 10.2174/1573399816999201110195222.
3
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
4
Public acceptance of COVID-19 vaccination among residents of Saudi Arabia: a cross-sectional online study.
BMJ Open. 2022 Oct 31;12(10):e058180. doi: 10.1136/bmjopen-2021-058180.
5
Acceptance and barriers of COVID-19 vaccination among people with chronic diseases in Saudi Arabia.
J Infect Dev Ctries. 2021 Nov 30;15(11):1646-1652. doi: 10.3855/jidc.15063.
6
COVID-19 vaccine hesitancy among patients with diabetes in Saudi Arabia.
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102271. doi: 10.1016/j.dsx.2021.102271. Epub 2021 Sep 4.
7
Assessment of caregivers' perspectives regarding speech-language services in Saudi Arabia during COVID-19.
PLoS One. 2021 Jun 22;16(6):e0253441. doi: 10.1371/journal.pone.0253441. eCollection 2021.
8
Spatial Analysis of COVID-19 Vaccine Centers Distribution: A Case Study of the City of Jeddah, Saudi Arabia.
Int J Environ Res Public Health. 2022 Mar 16;19(6):3526. doi: 10.3390/ijerph19063526.
9
Perception and Acceptance of Using Different Generic Types of COVID-19 Vaccine, the "Mix-and-Match" Strategy, in Saudi Arabia: Cross-Sectional Web-Based Survey.
Int J Environ Res Public Health. 2022 Oct 26;19(21):13889. doi: 10.3390/ijerph192113889.
10
Willingness to receive COVID-19 vaccination among adults with chronic diseases in the Kingdom of Saudi Arabia.
J Infect Public Health. 2021 Oct;14(10):1489-1496. doi: 10.1016/j.jiph.2021.08.002. Epub 2021 Aug 13.

引用本文的文献

1
Dyslipidemia Associated With Type 2 Diabetes Mellitus as a Strong Predictor of ICU Admission in COVID-19 Patients: A Retrospective Comparative Study.
Cureus. 2025 Jul 2;17(7):e87193. doi: 10.7759/cureus.87193. eCollection 2025 Jul.
2
Changes in screening, diagnosis, management, and outcomes of gestational diabetes during the COVID-19 pandemic: A systematic review.
Heliyon. 2024 May 25;10(11):e31943. doi: 10.1016/j.heliyon.2024.e31943. eCollection 2024 Jun 15.
3
Prediction of in-hospital mortality rate in COVID-19 patients with diabetes mellitus using machine learning methods.
J Diabetes Metab Disord. 2023 May 13;22(2):1-14. doi: 10.1007/s40200-023-01228-y.
4
The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study.
Viruses. 2023 Jan 24;15(2):326. doi: 10.3390/v15020326.
5
A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes.
Int J Med Sci. 2023 Jan 1;20(1):142-150. doi: 10.7150/ijms.77206. eCollection 2023.
6
COVID-19 and Diabetes Mellitus: From Pathophysiology to Clinical Management.
Cureus. 2022 Nov 25;14(11):e31895. doi: 10.7759/cureus.31895. eCollection 2022 Nov.
7
Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.
Front Microbiol. 2022 Aug 31;13:974205. doi: 10.3389/fmicb.2022.974205. eCollection 2022.
8
Prevalence of COVID-19 Infection among Patients with Diabetes and Their Vaccination Coverage Status in Saudi Arabia: A Cross-Sectional Analysis from a Hospital-Based Diabetes Registry.
Vaccines (Basel). 2022 Feb 16;10(2):310. doi: 10.3390/vaccines10020310.
9
Digital Health Platforms in Saudi Arabia: Determinants from the COVID-19 Pandemic Experience.
Healthcare (Basel). 2021 Nov 8;9(11):1517. doi: 10.3390/healthcare9111517.

本文引用的文献

1
Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia.
Vaccines (Basel). 2021 Jun 18;9(6):674. doi: 10.3390/vaccines9060674.
2
Launching COVID-19 vaccination in Saudi Arabia: Lessons learned, and the way forward.
Travel Med Infect Dis. 2021 Sep-Oct;43:102119. doi: 10.1016/j.tmaid.2021.102119. Epub 2021 Jun 13.
3
Clinical and demographic characteristics of patients with coronavirus disease 2019 in Security Forces Hospital, Riyadh, Saudi Arabia.
J Family Med Prim Care. 2021 Feb;10(2):947-952. doi: 10.4103/jfmpc.jfmpc_1484_20. Epub 2021 Feb 27.
4
A comprehensive review and update on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus disease 2019 (COVID-19): what do we know now in 2021?
Arch Med Sci Atheroscler Dis. 2021 Apr 6;6:e5-e13. doi: 10.5114/amsad.2021.105065. eCollection 2021.
5
Epidemiological, clinical, and laboratory findings for patients of different age groups with confirmed coronavirus disease 2019 (COVID-19) in a hospital in Saudi Arabia.
PLoS One. 2021 Apr 29;16(4):e0250955. doi: 10.1371/journal.pone.0250955. eCollection 2021.
6
The Impact of COVID-19 Pandemic Lockdown on the Incidence of New-Onset Type 1 Diabetes and Ketoacidosis Among Saudi Children.
Front Endocrinol (Lausanne). 2021 Apr 1;12:669302. doi: 10.3389/fendo.2021.669302. eCollection 2021.
7
Type 2 Diabetes Mellitus and COVID-19: A Narrative Review.
Front Endocrinol (Lausanne). 2021 Mar 31;12:609470. doi: 10.3389/fendo.2021.609470. eCollection 2021.
8
Diabetes and COVID-19.
Open Life Sci. 2021 Mar 25;16(1):297-302. doi: 10.1515/biol-2021-0034. eCollection 2021.
9
Newly diagnosed diabetes in patients with mild to moderate COVID-19.
Diabetes Metab Syndr. 2021 Mar-Apr;15(2):569-571. doi: 10.1016/j.dsx.2021.02.034. Epub 2021 Mar 3.
10
Predictors of Hospitalization Among Older Adults with COVID-19 in Saudi Arabia: A Cross-Sectional Study of a Nationally Representative Sample.
Risk Manag Healthc Policy. 2021 Mar 3;14:875-886. doi: 10.2147/RMHP.S294786. eCollection 2021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验